Home

5 Revealing Analyst Questions From IMAX’s Q1 Earnings Call

IMAX Cover Image

IMAX’s first quarter of 2025 saw revenue and adjusted profit surpass Wall Street expectations, yet the market responded negatively. Management credited the strong results to robust global box office performance, especially in China, and a record number of new system signings and the second-best first quarter ever for system installations. CEO Richard Gelfond pointed to the success of local language films and an expanded mix of content, noting, “Chinese New Year exceeded our wildest expectations with $182 million in IMAX box office, triple our previous record.”

Is now the time to buy IMAX? Find out in our full research report (it’s free).

IMAX (IMAX) Q1 CY2025 Highlights:

  • Revenue: $86.67 million vs analyst estimates of $84.23 million (9.5% year-on-year growth, 2.9% beat)
  • Adjusted EPS: $0.13 vs analyst estimates of $0.11 (14.4% beat)
  • Adjusted EBITDA: $28.05 million vs analyst estimates of $27.9 million (32.4% margin, 0.5% beat)
  • Operating Margin: 19.3%, up from 15.3% in the same quarter last year
  • Market Capitalization: $1.43 billion

While we enjoy listening to the management's commentary, our favorite part of earnings calls are the analyst questions. Those are unscripted and can often highlight topics that management teams would rather avoid or topics where the answer is complicated. Here is what has caught our attention.

Our Top 5 Analyst Questions IMAX’s Q1 Earnings Call

  • Eric Wold (Texas Capital Securities) asked about the impact of China’s reduced Hollywood film import policy. CEO Richard Gelfond responded that major Hollywood titles are still being approved and that demand within China remains strong, with “no reduction in activity.”
  • Chad Beynon (Macquarie) inquired whether the Q1 outperformance in China was driven by specific city tiers. Gelfond stated the strength was uniform and credited unique marketing strategies, particularly social media campaigns, for broad-based success.
  • David Karnovsky (JPMorgan) questioned the effect of shorter theatrical windows on IMAX’s business. Gelfond explained that windowing has limited impact, emphasizing content quality and diversification as more critical to long-term performance.
  • Steven Frankel (Rosenblatt Securities) asked about potential gross margin pressure from more labor-intensive remastering processes. Gelfond said increased automation and cloud-based processing have improved efficiency, reducing margin risk.
  • Omar Mejias Santiago (Wells Fargo) sought insight into how economic slowdowns could affect consumer demand, particularly in China. Gelfond and CFO Natasha Fernandes both pointed to recent record performance during a slow period as evidence of resilience, with Fernandes noting ongoing government support.
  • Patrick Sholl (Barrington Research) asked about managing available dating slots for IMAX films and balancing international distribution. Gelfond explained that the company is able to balance the slate and find opportunities to bring back high-performing titles throughout the year.
  • Mike Hickey (Benchmark Company) questioned the risk of Hollywood studios delaying films for China approval and potential brand sensitivity in China. Gelfond emphasized high confidence in approvals for major titles and noted that IMAX is perceived as a local prestige brand in China, not subject to negative sentiment.

Catalysts in Upcoming Quarters

In the coming quarters, key catalysts to monitor include: (1) the release and box office performance of upcoming Hollywood and local language blockbusters, (2) the pace of new system installations and signings in key international markets, and (3) the effectiveness of digital marketing strategies in driving audience engagement. Additional attention will be paid to potential policy changes affecting film imports and evolving consumer demand trends.

IMAX currently trades at $26.83, up from $24.05 just before the earnings. In the wake of this quarter, is it a buy or sell? The answer lies in our full research report (it’s free).

High-Quality Stocks for All Market Conditions

The market surged in 2024 and reached record highs after Donald Trump’s presidential victory in November, but questions about new economic policies are adding much uncertainty for 2025.

While the crowd speculates what might happen next, we’re homing in on the companies that can succeed regardless of the political or macroeconomic environment. Put yourself in the driver’s seat and build a durable portfolio by checking out our Top 5 Growth Stocks for this month. This is a curated list of our High Quality stocks that have generated a market-beating return of 183% over the last five years (as of March 31st 2025).

Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,545% between March 2020 and March 2025) as well as under-the-radar businesses like the once-small-cap company Comfort Systems (+782% five-year return). Find your next big winner with StockStory today.